New anticoagulant agents in acute coronary syndromes

Heart. 2011 Feb;97(3):244-52. doi: 10.1136/hrt.2009.184333.
No abstract available

Publication types

  • Review

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Anticoagulants / therapeutic use*
  • Antithrombins / therapeutic use
  • Cyclic N-Oxides / therapeutic use
  • Fondaparinux
  • Hirudins
  • Humans
  • Morpholines / therapeutic use
  • Peptide Fragments / therapeutic use
  • Polysaccharides / therapeutic use
  • Pyrazoles / therapeutic use
  • Pyridines / therapeutic use
  • Pyridones / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Rivaroxaban
  • Thiophenes / therapeutic use

Substances

  • Anticoagulants
  • Antithrombins
  • Cyclic N-Oxides
  • Hirudins
  • Morpholines
  • Peptide Fragments
  • Polysaccharides
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Recombinant Proteins
  • Thiophenes
  • apixaban
  • Rivaroxaban
  • Fondaparinux
  • otamixaban
  • bivalirudin